Applying Computational Phenotypes To Assess Mental Health Disorders Among Transgender Patients in the United States

应用计算表型评估美国跨性别患者的心理健康障碍

基本信息

  • 批准号:
    10604723
  • 负责人:
  • 金额:
    $ 3.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Transgender (TG) individuals have high prevalence of depression (64%) and are nearly nine times as likely to attempt suicide compared to the general population. Studies have not consistently collected data related to TG identity nor have they used the recommended two-step method of asking for assigned sex at birth and current gender identity. This population is largely overlooked in epidemiologic studies due to small sample size. With inconsistent and inaccurate ascertainment of TG patients in real-world data sources, TG people are missed and their health trends over time are understudied. Researchers are unable to identify and meaningfully address mental health inequities for this population, which can further exacerbate and perpetuate psychiatric conditions. It remains unclear what the health care utilization trends are for TG patients with psychiatric disorders and their adherence and persistence to psychiatric medications over time. Understanding this population’s mental health using large datasets is imperative in order to optimize the care management of psychiatric conditions experienced by TG people. The objectives of this proposal are to: (1) apply and evaluate the performance of existing computational phenotypes (CPs) to identify TG patients with depressive disorders (DD), anxiety, and attention deficit disorders (ADD), (2) assess adherence and prevalence of psychiatric medications among TG patients diagnosed with psychiatric disorders compared to cisgender patients with these diagnoses, and (3) examine the risk of non-fatal self-harm among TG patients with psychiatric disorders receiving psychotherapy compared to TG patients not receiving psychotherapy. For all aims, IBM MarketScan from years 2008 to 2020 will be used, which is a large, longitudinal medical claims database that includes inpatient and outpatient visits and prescription medication use. The completion of the proposed aims will provide real-world evidence on mental health care for TG individuals in the United States. The training plan outlined in this proposal will equip the applicant with critical knowledge and necessary skills in social and pharmacoepidemiology and transgender mental health. This plan will prepare him to successfully complete the proposed aims and to progress into a role as an independent, interdisciplinary researcher studying the intersection of pharmacoepidemiology and transgender health equity in the US. The applicant is extremely well supported by an interdisciplinary group of social, psychiatric, and pharmacoepidemiology faculty, health disparities researchers, and pharmaceutical researchers with the requisite expertise to support his doctoral research and prepare him for the next phase of his career.
项目摘要 跨性别者(TG)抑郁症的患病率很高(64%), 与一般人群相比,自杀未遂。研究没有一致地收集与TG相关的数据 他们也没有使用建议的两步方法,要求在出生时指定性别, 性别认同由于样本量小,这一人群在流行病学研究中很大程度上被忽视。与 真实世界数据源中TG患者的确定不一致和不准确,TG患者被遗漏 他们的健康趋势也没有得到充分的研究。研究人员无法识别和有意义的 解决这一人群的心理健康不平等问题,这可能进一步加剧和延续精神疾病, 条件目前尚不清楚TG精神病患者的卫生保健利用趋势是什么, 疾病及其随时间对精神药物的依从性和持久性。理解这一 人口的心理健康使用大型数据集是必要的,以优化护理管理, TG患者的精神状况。 该建议的目标是:(1)应用和评估现有的计算性能 表型(CP)用于识别患有抑郁症(DD)、焦虑和注意力缺陷的TG患者 (2)评估TG患者中精神药物的依从性和患病率 与患有这些诊断的顺性别患者相比,被诊断患有精神疾病,以及(3) 检查接受精神疾病治疗的TG患者非致命性自我伤害的风险, 与未接受心理治疗的TG患者相比。为了实现所有目标,来自 将使用2008年至2020年,这是一个大型纵向医疗索赔数据库,包括 住院和门诊就诊以及处方药的使用。完成拟议目标将 提供真实世界的证据,在美国的TG个人的精神卫生保健。 本建议书中概述的培训计划将使申请人具备关键知识和必要的 社会和药物流行病学以及跨性别心理健康方面的技能。这个计划将使他准备好 成功地完成拟议的目标,并逐步成为一个独立的,跨学科的作用, 研究药物流行病学和跨性别健康公平的交叉在美国的研究员。 申请人得到了社会,精神病学和心理学跨学科小组的大力支持。 药物流行病学教师,健康差异研究人员和制药研究人员与 必要的专业知识来支持他的博士研究并为他职业生涯的下一阶段做好准备。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Theo Beltran其他文献

Theo Beltran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 3.97万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了